Bio-Rad Laboratories Inc (BIO)

Receivables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	2,566,525	2,580,209	2,562,604	2,605,238	2,671,262	2,720,366	2,769,042	2,779,031	2,802,249	2,804,730	2,870,979	2,895,811	2,922,545	2,979,615	2,879,829	2,700,778	2,545,626	2,380,215	2,293,585	2,329,324
Receivables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $2,566,525K ÷ $—K
= —

Based on the data provided, Bio-Rad Laboratories Inc's receivables turnover ratio is not available for the periods mentioned. The receivables turnover ratio is a financial metric that indicates how efficiently a company collects outstanding receivables from its customers during a specific period.

A higher receivables turnover ratio generally suggests that the company is effective in collecting payments from its customers promptly. Conversely, a lower ratio may indicate potential issues with collecting receivables in a timely manner, which could lead to cash flow problems or liquidity issues.

Since the receivables turnover ratio data is unavailable for the specified periods, it is not possible to assess how efficiently Bio-Rad Laboratories Inc is managing its accounts receivable during those time frames. Investors and analysts typically use this ratio to evaluate the effectiveness of a company's credit and collection policies, so the absence of this information may limit a comprehensive analysis of Bio-Rad Laboratories Inc's financial performance in relation to its receivables management.